|
ORIGINAL HISTOLOGICAL DIAGNOSIS
|
FINAL DIAGNOSIS AFTER IMMUNOHISTOCHEMISTRY
|
AGE GROUP (years)
|
GENDER
|
TOPOGRAPHY
|
|---|
|
Carcinoma
|
Neuroendocrine carcinoma
|
25-44
|
Male
|
Lymph node
|
|
Carcinoma
|
Neuroendocrine carcinoma
|
45-64
|
Female
|
Nose
|
|
Carcinoma
|
Neuroendocrine carcinoma
|
45-64
|
Male
|
Nasopharynx
|
|
Carcinoma
|
Neuroendocrine carcinoma
|
25-44
|
Female
|
Nose
|
|
Carcinoma
|
Neuroendocrine carcinoma
|
15-24
|
Male
|
Palate
|
|
Carcinoma
|
Neuroendocrine carcinoma
|
≥65
|
Male
|
Nasopharynx
|
|
Carcinoma
|
Sarcoma
|
25-44
|
Male
|
Face/scalp
|
|
Carcinoma
|
Sarcoma
|
15-24
|
Male
|
Nasopharynx
|
|
Carcinoma
|
Sarcoma
|
45-64
|
Male
|
Lymph node
|
|
Carcinoma
|
Sarcoma
|
25-44
|
Male
|
Nasopharynx
|
|
Carcinoma
|
Sarcoma
|
25-44
|
Male
|
Nose
|
|
Carcinoma
|
Sarcoma
|
15-24
|
Male
|
Nose
|
|
Carcinoma
|
Sarcoma
|
45-64
|
Male
|
Nasopharynx
|
|
Carcinoma
|
Sarcoma
|
45-64
|
Female
|
Maxillofacial bone
|
|
Carcinoma
|
Lymphoma
|
≥65
|
Male
|
Nasopharynx
|
|
Carcinoma
|
Lymphoma
|
45-64
|
Male
|
Nasopharynx
|
|
Carcinoma
|
Lymphoma
|
25-44
|
Male
|
Oropharynx
|
|
Carcinoma
|
Lymphoma
|
----
|
Male
|
Oropharynx
|
|
Carcinoma
|
Lymphoma
|
15-24
|
Male
|
Maxillofacial bone
|
|
Carcinoma
|
Lymphoma
|
45-64
|
Male
|
Nose
|
|
Carcinoma
|
Lymphoma
|
25-44
|
Female
|
Nasopharynx
|
|
Carcinoma
|
Lymphoma
|
45-64
|
Female
|
Nasopharynx
|
|
Carcinoma
|
Carcinosarcoma
|
45-64
|
Male
|
Nasopharynx
|
|
Sarcoma
|
Carcinoma
|
45-64
|
Female
|
Face/scalp
|
|
Sarcoma
|
Lymphoma
|
15-24
|
Male
|
Maxillofacial bone
|
|
Sarcoma
|
Lymphoma
|
25-44
|
Male
|
Maxillofacial bone
|
|
Lymphoma
|
Sarcoma
|
25-44
|
Male
|
Nose
|
|
Neuroendocrine carcinoma
|
Sarcoma
|
45-64
|
Male
|
Nasopharynx
|
